CG ONCOLOGY INC. Earnings Dividend

CG ONCOLOGY INC.’s revenue jumped 409.21% since last year same period to $2.32Mn in the Q4 2025. On a quarterly growth basis, CG ONCOLOGY INC. has generated 39.38% jump in its revenue since last 3-months.

CG ONCOLOGY INC.’s net profit fell -29.91% since last year same period to $-41.31Mn in the Q4 2025. On a quarterly growth basis, CG ONCOLOGY INC. has generated 5.7% jump in its net profits since last 3-months.

CG ONCOLOGY INC.’s net profit margin jumped 74.49% since last year same period to -1779.03% in the Q4 2025. On a quarterly growth basis, CG ONCOLOGY INC. has generated 32.34% jump in its net profit margins since last 3-months.

CG ONCOLOGY INC.’s earning per share (EPS) estimates for the current quarter stand at -0.48 - a 12.2% jump from last quarter’s estimates.

CG ONCOLOGY INC.’s earning per share (EPS) estimates for the current year stand at -0.48.

CG ONCOLOGY INC.’s earning per share (EPS) fell -10.87% since last year same period to -0.51 in the Q4 2025. This indicates that the CG ONCOLOGY INC. has generated -10.87% annual rate of fall in its earning per share (EPS) in the last 4 quarters.